Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2026-06-18 16:31:08 ET · period of report 2026-06-18 · accession 0001231589-26-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-18 16:31 | 2026-06-18 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $146.03 | +8,300 | 53.5K | +18% | +$1.21M |
| DMT | 2026-06-18 16:31 | 2026-06-18 | UTHR | MAHON PAUL A | EVP, GC | S - Sale+OE | $541.55 | -8,300 | 45.2K | -16% | -$4.49M |
| DT | 2026-06-18 16:31 | 2026-06-18 | UTHR | MAHON PAUL A | EVP, GC | M - OptEx | $0.00 | -8,300 | 97.3K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-18 | M | A | 8,300 | $146.03 | 53,472 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 2 | Common | Common Stock | 2026-06-18 | S | D | 1,715 | $537.04 | 51,757 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $536.495 to $537.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2026-06-18 | S | D | 958 | $538.03 | 50,799 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $537.58 to $538.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2026-06-18 | S | D | 1,305 | $539.42 | 49,494 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $538.86 to $539.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2026-06-18 | S | D | 798 | $540.25 | 48,696 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $539.865 to $540.84. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2026-06-18 | S | D | 950 | $541.25 | 47,746 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $540.87 to $541.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2026-06-18 | S | D | 160 | $541.95 | 47,586 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |
| 8 | Common | Common Stock | 2026-06-18 | S | D | 480 | $544.26 | 47,106 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $544.215 to $545.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Common | Common Stock | 2026-06-18 | S | D | 157 | $546.15 | 46,949 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $545.88 to $546.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 10 | Common | Common Stock | 2026-06-18 | S | D | 881 | $547.65 | 46,068 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F9) This transaction was executed in multiple trades at prices ranging from $547.13 to $547.945. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 11 | Common | Common Stock | 2026-06-18 | S | D | 496 | $548.91 | 45,572 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F10) This transaction was executed in multiple trades at prices ranging from $548.415 to $549.165. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 12 | Common | Common Stock | 2026-06-18 | S | D | 400 | $551.74 | 45,172 | D | — | — | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. (F11) This transaction was executed in multiple trades at prices ranging from $551.50 to $551.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 13 | Derivative | Stock Option | 2026-06-18 | M | D | 8,300 | $0.00 | 97,340 | D | $146.03 · 2020-03-15 to 2027-03-15 | 8,300 Common Stock | (F1) This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 11, 2025. |